When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - Bristol-Myers Squibb: Great Deal On Celgene And Undervalued
Bristol-Myers Squibb Company
In June 2018, I have written my first and only article on Celgene (CELG) so far. In the article, I calculated an intrinsic value for Celgene of $100 (in the worst case) and ended the article with the advice to open a long position at $67, which would be a good long-term entry point. In December 2018, the stock price dropped even below that level, but before I could open any long position, Bristol-Myers Squibb (BMY) announced on January 3, 2019, that it will acquire Celgene.